AntiTum Cancer Research Results
AntiTum, AntiTumor: Click to Expand ⟱
ESCC, Oesophageal Squamous Cell Carcinoma: Click to Expand ⟱
Esophageal cancer is a growth of cells that starts in the esophagus.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
ESCC, |
KYSE-30 |
|
|
|
*AntiP↑, AntiTum↑, ER Stress↑, TumAuto↑, ATF4↑, CHOP/DDIT3↝, TumCG↓, PERK↑, ROS↑, *toxicity↓, Ca+2↑,
| - |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
- |
in-vitro, |
ESCC, |
EC9706 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
tumCV↓, TumCCA↑, Apoptosis↑, EGFR↓, PI3K↓, Hif1a↓, PKM2↓, cycD1/CCND1↓, AntiTum↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
PKM2↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↝, 1, ER Stress↑, 1, PERK↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
ATF4↑, 1, EGFR↓, 1, Hif1a↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 2,
Total Targets: 18
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiP↑, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 2
Scientific Paper Hit Count for: AntiTum, AntiTumor
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:41 Cells:% prod#:% Target#:913 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page